Form D · Biotechnology

GALLEON PHARMACEUTICALS INC

Horsham, PA · CIK 0001387973

Offering snapshot reported Nov 20, 2013 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 6, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 20, 2013Initial$1,500,000No comparison3SEC filing
Nov 15, 2010Initial$10,000,001No comparison3SEC filing
Nov 14, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jan 23, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-206691
Securities offered consist of promissory notes convertible into shares of convertible preferred stock and the common stock underlying the convertible preferred stock.

Source: Form D, filed Nov 20, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ralph Christoffersen Director
Thomas J. Dietz Director
Geoff Duyk Director
James C. Mannion Director, Executive
Chris Mirabelli Director
Christopher Mirabelli Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
213 Witmer Road
Horsham, PA, 19044